PMID- 32957323
OWN - NLM
STAT- MEDLINE
DCOM- 20200929
LR  - 20231003
IS  - 1536-5964 (Electronic)
IS  - 0025-7974 (Print)
IS  - 0025-7974 (Linking)
VI  - 99
IP  - 38
DP  - 2020 Sep 18
TI  - The effect of qigong for pulmonary function and quality of life in patients with 
      covid-19: A protocol for systematic review and meta-analysis.
PG  - e22041
LID - 10.1097/MD.0000000000022041 [doi]
LID - e22041
AB  - BACKGROUND: Qigong is a traditional Chinese exercise method for health care, 
      keeping fit and getting rid of diseases. It has the advantages of simple 
      operation and few side effects. Corona Virus Disease 2019 (COVID-19) is an acute 
      respiratory infectious disease caused by severe acute respiratory syndrome 
      coronavirus 2(SARS-COV-2). Its clinical manifestations mainly include fever, 
      fatigue, and dry cough. Clinical practice showed that Qigong had some therapeutic 
      effects on pulmonary dysfunction caused by novel Coronavirus, but there was 
      lacking in evidence of evidence-based medicine. The purpose of this protocol is 
      to systematically evaluate the effects of Qigong on lung function and quality of 
      life in COVID-19 patients, and to add evidence to evidence-based medicine for the 
      clinical application of Qigong therapy. METHODS: Use computer to retrieve English 
      database (PubMed, Embase, Web of Science, the Cochrane Library) and Chinese 
      database (China Knowledge Network (CNKI), Wanfang Database, VIP Information 
      Chinese Journal Service Platform (VIP), Chinese Biomedical Database). In 
      addition, we manually retrieve randomized controlled clinical research from Baidu 
      academic and Google academic from its establishment to July 2020. Two researchers 
      independently extracted and evaluated the quality of the data included in the 
      study, using RevMan5.3 to do meta-analyses of articles included, without language 
      restrictions. RESULTS: This research evaluated the effectiveness and safety of 
      Qigongs influence on patients pulmonary function and life quality by index such 
      as 6-minute walk distance (6MWD), Forced expiratory volume in 1 second (FEV1), 
      Forced vital capacity (FVC), Forced expiratory volume in 1 second/Forced vital 
      capacity (FEV1/FVC), Forced expiratory volume in 1 second/prediction (FEV1/PRE), 
      Self-rating anxiety scale (SAS), etc. CONCLUSIONS:: This study will provide 
      reliable evidence-based evidence for the clinical application of Qigong in the 
      treatment of COVID-19. PROSPERO REGISTRATION NUMBER: CRD42020191877.
FAU - Peng, Jing
AU  - Peng J
AD  - Department of Outpatient.
FAU - Wu, Zhimin
AU  - Wu Z
AD  - Department of Gynaecology and Obstetrics.
FAU - Zhong, Hongling
AU  - Zhong H
AD  - Department of Outpatient.
FAU - Zhou, Yaying
AU  - Zhou Y
AD  - Department of Anesthesiology.
FAU - Wang, Li
AU  - Wang L
AD  - Department of Anesthesiology.
FAU - Wang, Yu
AU  - Wang Y
AD  - Department of Neurology, The First Hospital Affiliated Tsmall o, Cyrillic AMU (Southwest 
      Hospital).
FAU - Luo, Wei
AU  - Luo W
AD  - Department of Respiratory and Critical Care Medicine, Chongqing Jiangbei Hospital 
      of Traditional Chinese Medicine.
FAU - Liu, Ya
AU  - Liu Y
AD  - Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine, 
      Chongqing , China.
FAU - Zhang, Linglin
AU  - Zhang L
AUID- ORCID: 0000-0002-3263-6981
AD  - Department of Anesthesiology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Medicine (Baltimore)
JT  - Medicine
JID - 2985248R
SB  - IM
MH  - *Betacoronavirus
MH  - COVID-19
MH  - Coronavirus Infections/physiopathology/psychology/*therapy/virology
MH  - Humans
MH  - Lung/physiopathology
MH  - Medicine, Chinese Traditional/*methods
MH  - Meta-Analysis as Topic
MH  - Pandemics
MH  - Pneumonia, Viral/physiopathology/psychology/*therapy/virology
MH  - Qigong/*methods
MH  - *Quality of Life
MH  - Research Design
MH  - Respiratory Function Tests
MH  - SARS-CoV-2
MH  - Systematic Reviews as Topic
MH  - Treatment Outcome
PMC - PMC7505404
EDAT- 2020/09/23 06:00
MHDA- 2020/09/30 06:00
PMCR- 2020/09/18
CRDT- 2020/09/22 01:02
PHST- 2020/09/22 01:02 [entrez]
PHST- 2020/09/23 06:00 [pubmed]
PHST- 2020/09/30 06:00 [medline]
PHST- 2020/09/18 00:00 [pmc-release]
AID - 00005792-202009180-00020 [pii]
AID - MD-D-20-07643 [pii]
AID - 10.1097/MD.0000000000022041 [doi]
PST - ppublish
SO  - Medicine (Baltimore). 2020 Sep 18;99(38):e22041. doi: 
      10.1097/MD.0000000000022041.